This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2002 Dec;25(12):2363-4; author reply 2364-5.

doi: 10.2337/diacare.25.12.2363.

Clinical heterogeneity of patients with adult-onset diabetes and GAD autoantibodies

Michiaki Fukui, Yoshihiro Kitagawa, Naoto Nakamura, Toshikazu Yoshikawa

PMID: 12453997
DOI: 10.2337/diacare.25.12.2363

Comment

Clinical heterogeneity of patients with adult-onset diabetes and GAD autoantibodies

Michiaki Fukui et al. Diabetes Care. 2002 Dec.

. 2002 Dec;25(12):2363-4; author reply 2364-5.

doi: 10.2337/diacare.25.12.2363.

Authors

Michiaki Fukui, Yoshihiro Kitagawa, Naoto Nakamura, Toshikazu Yoshikawa

PMID: 12453997
DOI: 10.2337/diacare.25.12.2363

No abstract available

PubMed Disclaimer

Comment on

Clinical, autoimmune, and genetic characteristics of adult-onset diabetic patients with GAD autoantibodies in Japan (Ehime Study).
Takeda H, Kawasaki E, Shimizu I, Konoue E, Fujiyama M, Murao S, Tanaka K, Mori K, Tarumi Y, Seto I, Fujii Y, Kato K, Kondo S, Takada Y, Kitsuki N, Kaino Y, Kida K, Hashimoto N, Yamane Y, Yamawaki T, Onuma H, Nishimiya T, Osawa H, Saito Y, Makino H; Ehime Study. Takeda H, et al. Diabetes Care. 2002 Jun;25(6):995-1001. doi: 10.2337/diacare.25.6.995. Diabetes Care. 2002. PMID: 12032105

Similar articles

GAD antibodies in classification of Asian type 2 diabetes.
Fukui M, Nakamura N, Kondo M. Fukui M, et al. Diabetes Care. 1999 Jun;22(6):1011-2. doi: 10.2337/diacare.22.6.1011. Diabetes Care. 1999. PMID: 10372266 No abstract available.
[When and why should anti-GAD antibodies by looked for in the non-insulin-dependent diabetic patient?].
Atlan-Gepner C, Vialettes B. Atlan-Gepner C, et al. Diabetes Metab. 1999 Jun;25(2):177-9. Diabetes Metab. 1999. PMID: 10443330 Review. French. No abstract available.
GAD antibodies in IDDM in Thailand.
Rattarasarn C, Aguilar-Diosdado M, Soonthornpun S, Patarakijvanich N, Jaruratanasirikul S. Rattarasarn C, et al. Diabetes Care. 1996 Jun;19(6):674-5. doi: 10.2337/diacare.19.6.674. Diabetes Care. 1996. PMID: 8725876 No abstract available.
Seroconversion of GAD antibody in unclassified diabetes with long duration of disease.
Shigihara T, Shimada A, Saisho Y, Kawai T, Maruyama H, Saruta T. Shigihara T, et al. Diabetes Care. 2004 Jul;27(7):1836-7. doi: 10.2337/diacare.27.7.1836-a. Diabetes Care. 2004. PMID: 15220276 No abstract available.
[Clinical relevance of anti-GAD antibody in IDDM and NIDDM].
Takahashi K, Satoh J, Toyota T. Takahashi K, et al. Nihon Rinsho. 1997 Nov;55 Suppl:319-23. Nihon Rinsho. 1997. PMID: 9434487 Review. Japanese. No abstract available.

See all similar articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information